Evidence map›Paper›PMID 34777356›Full record

ArticleFrontiers in immunology2021

RASAL3 Is a Putative RasGAP Modulating Inflammatory Response by Neutrophils.

Suguru Saito, Duo-Yao Cao, Aaron R Victor, Zhenzi Peng, Hui-Ya Wu, Derick Okwan-Duodu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. miScience · 2023
    Article
  11. Oral administration ofBioscience of microbiota, food and health · 2023
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Suguru SaitoBio-fluid Biomarker Center, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
Duo-Yao CaoDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Aaron R VictorDepartment of Pathology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Zhenzi PengDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Hui-Ya WuCollege of Health Science, Trans World University, Douliu, Taiwan.
Derick Okwan-DuoduDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Cedars-Sinai Medical Center · USNiigata University · JPNorthwest A&F University · CNTransWorld University · TW

Funding

Maladaptive Inflammation Impairs Collateral Vessel Formation in Sickle Cell DiseaseK99HL141638 · NHLBI · EMORY UNIVERSITY · PI OKWAN-DUODU, DERICK · 2019 to 2020
$210k
NHLBI NIH HHS K99 HL141638
6 · The paper itself

Abstract

As first responder cells in host defense, neutrophils must be carefully regulated to prevent collateral tissue injury. However, the intracellular events that titrate the neutrophil's response to inflammatory stimuli remain poorly understood. As a molecular switch, Ras activity is tightly regulated by Ras GTPase activating proteins (RasGAP) to maintain cellular active-inactive states. Here, we show that RASAL3, a RasGAP, is highly expressed in neutrophils and that its expression is upregulated by exogenous stimuli in neutrophils. RASAL3 deficiency triggers augmented neutrophil responses and enhanced immune activation in acute inflammatory conditions. Consequently, mice lacking RASAL3 (RASAL3-KO) demonstrate accelerated mortality in a septic shock model

Indexed as

AnimalsInflammationMiceMice, Inbred C57BLMice, KnockoutNeutrophilsras GTPase-Activating ProteinsRASAL3 protein, mouseras GTPase-Activating Proteinsacute inflammationlipopolysaccharide (LPS)neutrophilRASAL3RasGAPRas signal pathwaysepsis

Identifiers

PMID34777356
PMCPMC8579101
OpenAlexW3209418574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.